Lincoln, NE, United States of America

Richard L Sharpee

This inventor holds 5 USPTO granted patents. Top assignee: Norden Laboratories, Inc.. Active years: 1982-1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard L Sharpee. Retrieved from https://idiyas.com/inventor/richard-l-sharpee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 1982-1988

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Richard L. Sharpee

Introduction

Richard L. Sharpee is a notable inventor based in Lincoln, NE (US), recognized for his contributions to veterinary medicine. With a total of five patents to his name, Sharpee has made significant advancements in the field of immunization for animals.

Latest Patents

Among his latest patents is the development of an inactivated rabies vaccine for veterinary use. This innovative vaccine is designed for the immunization of canine and feline animals against the inactivated HCP-SAD strain of the rabies virus. The preparation of this vaccine represents a crucial step in protecting pets from this deadly disease.

Career Highlights

Sharpee's career is marked by his dedication to improving animal health through scientific research and innovation. His work at Norden Laboratories, Inc. has allowed him to focus on developing effective veterinary vaccines that enhance the well-being of animals.

Collaborations

One of his notable collaborators is Edmund P. Bass, who has worked alongside Sharpee in various projects aimed at advancing veterinary medicine.

Conclusion

Richard L. Sharpee's contributions to veterinary science through his patents and collaborative efforts highlight his commitment to animal health. His work continues to impact the field positively, ensuring better protection for pets against infectious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…